# PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

> **NCT00240162** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 21 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** PTK787/ZK 222584

## Key facts

- **NCT ID:** NCT00240162
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** investigator letter from drug manufacturer stating animal studies showed increased risk of cancer which was an unknown adverse event
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240162, "PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00240162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*